Posts

Showing posts with the label Pharmaceutical

Nutraceutical Excipients Market Expected to Reach US$2,427.8 Million by 2023

Image
Nutraceutical Excipients Market  Market Overview: The global nutraceutical excipients market is projected to reach a value of US$2,427.8 million in 2023, with a compound annual growth rate (CAGR) of 10.4% during the forecast period 2022-2030. Nutraceutical excipients are substances used in the formulation of nutraceutical products to enhance their stability, bioavailability, and effectiveness. These excipients play a crucial role in maintaining the quality, appearance, and consistency of nutraceutical products. The global market for nutraceutical excipients is driven by the increasing consumer demand for functional foods and dietary supplements, coupled with the rising awareness regarding the health benefits of nutraceutical products. Furthermore, advancements in excipient technologies and the development of novel excipients are anticipated to drive market growth in the coming years. Market Key Trends: Increasing Demand for Natural and Organic Nutraceutical Excipients The grow...

Global Diagnostic Radiopharmaceuticals and Contrast Media Market Is Estimated To Witness High Growth Owing To Rising Demand for Accurate Diagnosis and Imaging Techniques

Image
Diagnostic Radiopharmaceuticals and Contrast Media Market The global Diagnostic Radiopharmaceuticals and Contrast Media Market is estimated to be valued at US$ 6,811.4 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Diagnostic radiopharmaceuticals and contrast media are substances that are used during medical imaging procedures to provide enhanced images of internal organs and structures of the body. These products play a vital role in accurate diagnosis and help physicians to detect diseases such as cancer, cardiovascular disorders, and neurological conditions. They are commonly used in procedures such as X-ray, CT scan, MRI, and nuclear medicine imaging. The need for diagnostic radiopharmaceuticals and contrast media arises from the increasing prevalence of chronic diseases, growing geriatric population, and advancements in medical imaging technologies....